{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:03:34Z","timestamp":1785528214809,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101101187"],"award-info":[{"award-number":["101101187"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the status of low-dose CT lung cancer screening (LCS) training practices, identify existing gaps, and define key competencies to be included in LCS educational curricula.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>As part of the European SOLACE project, a structured cross-sectional survey consisting of 11 closed- and open-ended items, developed based on relevant literature, international guidelines, and expert input to assess LCS current practices and training needs, was administered to a panel of European LCS experts. Participants were invited to individual Zoom interviews (May\u2013November 2025). Data were analyzed using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-five LCS experts were interviewed from 14 European countries, including 10 radiologists (40%), 8 pulmonologists (32%), 4 thoracic surgeons (16%), 1 project manager (4%), 1 smoking cessation specialist (4%), and 1 general practitioner (GP) (4%). Reported training activities ranged from established programmes (4\/14 countries), to learning initiatives (6\/14) and\/or planned programmes (4\/14). Radiologists (96%), pulmonologists (80%), and GPs (60%) were identified as the main target groups for training. On a 6-point Likert scale (0\u2009=\u2009not important, 5\u2009=\u2009extremely important), experts indicated limited awareness of training needs as the most relevant gap (mean 2.8\u2009\u00b1\u20092.2). Key educational areas to be strengthened included management of incidental findings (4.5\u2009\u00b1\u20090.6) and confident use of guidelines for nodule management (3.8\u2009\u00b1\u20091.8). Among essential competencies for professionals involved in LCS, the highest-rated were competence in managing incidental findings (4.7\u2009\u00b1\u20090.6), familiarity with guideline-based nodule management (4.7\u2009\u00b1\u20090.6), basic knowledge of AI tools (4.5\u2009\u00b1\u20090.8), and communication with LCS participants (4.5\u2009\u00b1\u20091.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings suggest a heterogeneous LCS training landscape across European countries and underscore the importance of developing shared European curricula. Key priorities may include strengthening technical skills alongside structured communication training.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Education and training of all stakeholders are essential for the successful implementation of LCS programmes.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>This survey assesses the current status of LCS training practices across Europe, identifies existing gaps, and defines key competencies to inform future curricula for health professionals involved in LCS.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The European LCS training landscape is highly heterogeneous, with substantial variability in training activities, target professionals, and delivery modalities.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02362-w","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:07:06Z","timestamp":1785348426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Education and training in low-dose CT lung cancer screening across Europe: a survey study"],"prefix":"10.1186","volume":"17","author":[{"given":"Rebecca","family":"Mura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Zolda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Eufrasia","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Hardavella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kerpel-Fronius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten Gerriet","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-6364","authenticated-orcid":false,"given":"Helmut","family":"Prosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2362_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA A Cancer J Clin"},{"key":"2362_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.annonc.2023.01.010","volume":"34","author":"M Malvezzi","year":"2023","unstructured":"Malvezzi M, Santucci C, Boffetta P et al (2023) European cancer mortality predictions for the year 2023 with focus on lung cancer. Ann Oncol 34:410\u2013419. https:\/\/doi.org\/10.1016\/j.annonc.2023.01.010","journal-title":"Ann Oncol"},{"key":"2362_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/nejmoa1911793","volume":"382","author":"HJ De Koning","year":"2020","unstructured":"De Koning HJ, Van Der Aalst CM, De Jong PA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382:503\u2013513. https:\/\/doi.org\/10.1056\/nejmoa1911793","journal-title":"N Engl J Med"},{"key":"2362_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/nejmoa1102873","volume":"365","author":"The National Lung Screening Trial Research Team","year":"2011","unstructured":"The National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395\u2013409. https:\/\/doi.org\/10.1056\/nejmoa1102873","journal-title":"N Engl J Med"},{"key":"2362_CR5","doi-asserted-by":"publisher","first-page":"230190","DOI":"10.1183\/20734735.0190-2023","volume":"20","author":"G Hardavella","year":"2024","unstructured":"Hardavella G, Frille A, Sreter KB et al (2024) Lung cancer screening: Where do we stand? Breathe 20:230190. https:\/\/doi.org\/10.1183\/20734735.0190-2023","journal-title":"Breathe"},{"key":"2362_CR6","doi-asserted-by":"publisher","first-page":"1900506","DOI":"10.1183\/13993003.00506-2019","volume":"55","author":"H-U Kauczor","year":"2020","unstructured":"Kauczor H-U, Baird A-M, Blum TG et al (2020) ESR\/ERS statement paper on lung cancer screening. Eur Respir J 55:1900506. https:\/\/doi.org\/10.1183\/13993003.00506-2019","journal-title":"Eur Respir J"},{"key":"2362_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1183\/09031936.00033015","volume":"46","author":"H-U Kauczor","year":"2015","unstructured":"Kauczor H-U, Bonomo L, Gaga M et al (2015) ESR\/ERS white paper on lung cancer screening. Eur Respir J 46:28\u201339. https:\/\/doi.org\/10.1183\/09031936.00033015","journal-title":"Eur Respir J"},{"key":"2362_CR8","doi-asserted-by":"publisher","unstructured":"Kauczor H-U, Von Stackelberg O, Nischwitz E et al (2024) Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium. Insights Imaging. https:\/\/doi.org\/10.1186\/s13244-024-01814-5","DOI":"10.1186\/s13244-024-01814-5"},{"key":"2362_CR9","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1148\/rg.2015150079","volume":"35","author":"FJ Fintelmann","year":"2015","unstructured":"Fintelmann FJ, Bernheim A, Digumarthy SR et al (2015) The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program. Radiographics 35:1893\u20131908. https:\/\/doi.org\/10.1148\/rg.2015150079","journal-title":"Radiographics"},{"key":"2362_CR10","doi-asserted-by":"publisher","unstructured":"Adams SJ, Flores EJ, Little BP et al (2024) Radiographics update: the 10 pillars of lung cancer screening\u2014rationale and logistics of a lung cancer screening program. Radiographics. https:\/\/doi.org\/10.1148\/rg.230057","DOI":"10.1148\/rg.230057"},{"key":"2362_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jtho.2023.07.019","volume":"19","author":"S Lam","year":"2024","unstructured":"Lam S, Bai C, Baldwin DR et al (2024) Current and future perspectives on computed tomography screening for lung cancer: a roadmap from 2023 to 2027 from the International Association for the Study of Lung Cancer. J Thorac Oncol 19:36\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2023.07.019","journal-title":"J Thorac Oncol"},{"key":"2362_CR12","doi-asserted-by":"publisher","first-page":"2300128","DOI":"10.1183\/13993003.00128-2023","volume":"61","author":"DR Baldwin","year":"2023","unstructured":"Baldwin DR, O\u2019Dowd EL, Tietzova I et al (2023) Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard. Eur Respir J 61:2300128. https:\/\/doi.org\/10.1183\/13993003.00128-2023","journal-title":"Eur Respir J"},{"key":"2362_CR13","unstructured":"ESTI (2026) ESTI lung cancer screening certification project_ESTI LCS holders n.d. https:\/\/www.myesti.org\/lungcancerscreeningcertificationproject\/. Accessed 10 Dec 2026"},{"key":"2362_CR14","unstructured":"ESOR (2026) ESOR lung cancer screening course n.d. https:\/\/www.esor.org\/courses\/special-focus\/lung-cancer-screening-2nd-edition\/. Accessed 13 Apr 2026"},{"key":"2362_CR15","unstructured":"ACR (2026) ACR lung cancer screening education. https:\/\/www.acr.org\/Education-and-CME\/Cancer-Screening-and-Staging\/Lung-Cancer-Screening-Education. Accessed 13 Apr 2026"},{"key":"2362_CR16","unstructured":"NHS (2025) NHS_Quality assurance standards prepared for the targeted lung health checks programme. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/02\/PRN01867ii-quality-assurance-standards-prepared-for-the-lung-cancer-screening-programme-v3.pdf. Accessed 9 Dec 2025"},{"key":"2362_CR17","unstructured":"NHS (2025) NHS_Standard protocol prepared for the Lung Cancer Screening Programme. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/02\/PRN01867i-standard-protocol-prepared-for-the-lung-cancer-screening-programme-v3.pdf. Accessed 9 Dec 2025"},{"key":"2362_CR18","unstructured":"BC Cancer (2025) BC cancer lung screening standards and protocols. http:\/\/www.bccancer.bc.ca\/screening\/Documents\/Lung-Screening-Standards-Protocols.pdf. Accessed 9 Dec 2025"},{"key":"2362_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2019.06.024","volume":"135","author":"CJ Cadham","year":"2019","unstructured":"Cadham CJ, Jayasekera JC, Advani SM et al (2019) Smoking cessation interventions for potential use in the lung cancer screening setting: a systematic review and meta-analysis. Lung Cancer 135:205\u2013216. https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.024","journal-title":"Lung Cancer"},{"key":"2362_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jtho.2021.09.011","volume":"17","author":"R Meza","year":"2022","unstructured":"Meza R, Cao P, Jeon J et al (2022) Impact of joint lung cancer screening and cessation interventions under the new recommendations of the U.S. preventive services task force. J Thorac Oncol 17:160\u2013166. https:\/\/doi.org\/10.1016\/j.jtho.2021.09.011","journal-title":"J Thorac Oncol"},{"key":"2362_CR21","doi-asserted-by":"publisher","unstructured":"Ledda RE, Milanese G, Revel M-P, Snoeckx A (2025) Pros and cons of reporting incidental findings in lung cancer screening. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11580-7","DOI":"10.1007\/s00330-025-11580-7"},{"key":"2362_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1164\/rccm.202501-0011ST","volume":"211","author":"LM Henderson","year":"2025","unstructured":"Henderson LM, Kim RY, Tanner NT et al (2025) Lung cancer screening and incidental findings: a research agenda: an official American Thoracic Society Research Statement. Am J Respir Crit Care Med 211:436\u2013451. https:\/\/doi.org\/10.1164\/rccm.202501-0011ST","journal-title":"Am J Respir Crit Care Med"},{"key":"2362_CR23","doi-asserted-by":"publisher","first-page":"2300533","DOI":"10.1183\/13993003.00533-2023","volume":"62","author":"EL O\u2019Dowd","year":"2023","unstructured":"O\u2019Dowd EL, Tietzova I, Bartlett E et al (2023) ERS\/ESTS\/ESTRO\/ESR\/ESTI\/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. Eur Respir J 62:2300533. https:\/\/doi.org\/10.1183\/13993003.00533-2023","journal-title":"Eur Respir J"},{"key":"2362_CR24","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.21037\/tlcr-20-924","volume":"10","author":"A Snoeckx","year":"2021","unstructured":"Snoeckx A, Franck C, Silva M, Prokop M, Schaefer-Prokop C, Revel M-P (2021) The radiologist\u2019s role in lung cancer screening. Transl Lung Cancer Res 10:2356\u20132367. https:\/\/doi.org\/10.21037\/tlcr-20-924","journal-title":"Transl Lung Cancer Res"},{"key":"2362_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2214\/AJR.17.18836","volume":"210","author":"DB Green","year":"2018","unstructured":"Green DB, Pua BB, Crawford CB et al (2018) Screening for lung cancer: communicating with patients. AJR Am J Roentgenol 210:497\u2013502. https:\/\/doi.org\/10.2214\/AJR.17.18836","journal-title":"AJR Am J Roentgenol"},{"key":"2362_CR26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/thorax-2024-221662","volume":"79","author":"J Geppert","year":"2024","unstructured":"Geppert J, Asgharzadeh A, Brown A et al (2024) Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies. Thorax 79:1040\u20131049. https:\/\/doi.org\/10.1136\/thorax-2024-221662","journal-title":"Thorax"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02362-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02362-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:56Z","timestamp":1785521996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02362-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02362-w","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.P.: Speaker Honoria: AstraZeneca, BMS, Boehringer Ingelheim, Janssen, MSD, Novartis, Roche, Sanofi, Siemens Healthcare, Takeda. Advisory Boards: BMS, Boehringer Ingelheim, MSD, Roche\/Intermune, Sanofi. Travel grants: Boehringer Ingelheim. Research support: Boehringer Ingelheim, AstraZeneca, Siemens Healthineers, Austrian Federal Ministry for Labor and Economy, the National Foundation for Research, Technology and Development, and the Christian Doppler Research Association, EU Commission (EU4Health, Horizon Europe Health). The other authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"196"}}